BINDAZYME CLQ CIC EIA KIT

Complement C1q, Antigen, Antiserum, Control

THE BINDING SITE, LTD.

The following data is part of a premarket notification filed by The Binding Site, Ltd. with the FDA for Bindazyme Clq Cic Eia Kit.

Pre-market Notification Details

Device IDK031563
510k NumberK031563
Device Name:BINDAZYME CLQ CIC EIA KIT
ClassificationComplement C1q, Antigen, Antiserum, Control
Applicant THE BINDING SITE, LTD. WEST TOWER, SUITE 4000 2425 WEST OLYMPIC BOULEVARD Santa Monica,  CA  90404
ContactJay H Geller
CorrespondentJay H Geller
THE BINDING SITE, LTD. WEST TOWER, SUITE 4000 2425 WEST OLYMPIC BOULEVARD Santa Monica,  CA  90404
Product CodeDAK  
CFR Regulation Number866.5240 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2003-05-19
Decision Date2003-09-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.